Shares of Moderna Inc. MRNA, -2.07% slid 2.07% to $141.05 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index COMP, -1.25% falling 1.25% to 11,530.33 and Dow Jones Industrial Average DJIA, -1.72% falling 1.72% to 32,856.46. The stock’s fall snapped a three-day winning streak. Moderna Inc. closed $76.20 below its 52-week high ($217.25), which the company reached on December 14th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson JNJ, -0.94% fell 0.94% to $154.09 and Pfizer Inc. PFE, -1.87% fell 1.87% to $40.34. Trading volume (2.7 M) remained 1.3 million below its 50-day average volume of 4.0 M.